BioCentury | Nov 30, 2016
Distillery Therapeutics

Cancer

...testing for multiple other cancers. TARGET/MARKER/PATHWAY: c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene); CAP-GLY domain containing linker protein...
...as above email: david.jones@dkfz.de Steven Hochhauser German Cancer Research Center c-Met receptor tyrosine kinase (c-MET) (MET) (HGFR) (c-Met proto-oncogene) CAP-GLY domain containing linker protein...
Items per page:
1 - 1 of 1